Air Filtration Systems
Simple to install, these plug and play solutions have a patented dispersion method maximizing ion concentration where they are installed. They require no modification of existing air handling systems.
Needlepoint Bipolar Ionization (NPBI)
The NPBI technology works to safely clean the air inside your building. The patented technology uses an electronic charge to create a plasma field filled with a high concentration of + and – ions that replicate those commonly found in nature. As these ions travel with the air stream they attach to particles, pathogens and gases/odors. As the ions attach to airborne particles (including fine, sub-micron particles) they are then attracted to each other, making the particulate more easily filterable and increasing capture efficiency. The ions kill pathogens by robbing them of life-sustaining hydrogen. The ions breakdown harmful gases/odors into harmless compounds like O2, CO2, N2 and H2O.
Ambient Air Filtration
Our Ambient Air Filtration machines feature HEPA filtration along with Needlepoint Bipolar Ionization. This technology is 100% maintenance-free and is more effective than UV at cleaning surfaces, as NPBI can clean surfaces unseen to the eye. For UV to be effective, it needs direct contact with a surface, whereas NPBI acts in a form-fitting way to effectively clear 99.4% of SARS-CoV-2 (known as COVID-19) over 30-minute testing, per Innovative Bioanalysis third-party testing.
NPBI Has been proven to be effective against – Coronavirus, Norovirus, MRSA, Listeria, C-Diff, SARS, Strep, Legionella, E. Coli, and Swine Flu. NPBI is effective against VOCs, Odors, Mold, and Mildew; and causes the agglomeration of airborne contaminants like particulate or molecules, aiding filtration capture or causing them to drop out of breathing areas sooner by increasing their mass.
Ambient Air Filtration
Our Ambient Air Filtration machines feature HEPA filtration along with Needlepoint Bipolar Ionization. This technology is 100% maintenance-free and is more effective than UV at cleaning surfaces, as NPBI can clean surfaces unseen to the eye. For UV to be effective, it needs direct contact with a surface, whereas NPBI acts in a form-fitting way to effectively clear 99.4% of SARS-CoV-2 (known as COVID-19) over 30-minute testing, per Innovative Bioanalysis third-party testing.
NPBI Has been proven to be effective against – Coronavirus, Norovirus, MRSA, Listeria, C-Diff, SARS, Strep, Legionella, E. Coli, and Swine Flu. NPBI is effective against VOCs, Odors, Mold, and Mildew; and causes the agglomeration of airborne contaminants like particulate or molecules, aiding filtration capture or causing them to drop out of breathing areas sooner by increasing their mass.
Proven Effectiveness
Pathogen awareness and mitigation have become the highest of priorities as it relates to our personal safety and that of our customers and their employees. New third-party testing confirms that NBPI’s effectiveness is a solution that we can offer in the struggle against COVID-19.
How does this relate to our new NBPI offering?
- The patented NPBI technology being utilized in our ambient units now have a documented kill rate of COVID-19 virus of 99.4%.
- NBPI testing further suggests the technologies effectiveness in a “hierarchy-based” solution to future and pending threats.
|
Pathogen
|
Kill Rate
|
Test Agency
|
|---|---|---|
|
Tuberculosis
|
69.09%
|
EMSL
|
|
Norovirus
|
93.50%
|
ATS Labs
|
|
MRSA
|
96.24
|
EMSL
|
|
Staphylococcus
|
96.24
|
EMSL
|
|
Mold Spores
|
99.50%
|
GCA
|
|
E.coli
|
99.69%
|
EMSL
|
|
Coronavirus (COVID-19)
|
99.4%
|
EMSL
|
Proven Effectiveness
Pathogen awareness and mitigation have become the highest of priorities as it relates to our personal safety and that of our customers and their employees. New third-party testing confirms that NBPI’s effectiveness is a solution that we can offer in the struggle against COVID-19.
How does this relate to our new NBPI offering?
- The patented NPBI technology being utilized in our ambient units now have a documented kill rate of COVID-19 virus of 99.4%.
- NBPI testing further suggests the technologies effectiveness in a “hierarchy-based” solution to future and pending threats.
|
Pathogen
|
Kill Rate
|
Test Agency
|
|---|---|---|
|
Tuberculosis
|
69.09%
|
EMSL
|
|
Norovirus
|
93.50%
|
ATS Labs
|
|
MRSA
|
96.24
|
EMSL
|
|
Staphylococcus
|
96.24
|
EMSL
|
|
Mold Spores
|
99.50%
|
GCA
|
|
E.coli
|
99.69%
|
EMSL
|
|
Coronavirus (COVID-19)
|
99.4%
|
EMSL
|
Notable Users of NPBI Technology
Ready to get started?
Ready to start removing harmful pathogens from your process or do you still have lingering questions? Get in touch with us. We’d enjoy getting to hear more about your challenges and explain how we can help.
Ready to get started?
Ready to start removing harmful pathogens from your process or do you still have lingering questions? Get in touch with us. We’d enjoy getting to hear more about your challenges and explain how we can helps.